Dimensional Fund Advisors
ARLZ

Dimensional Fund Advisors’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Dimensional Fund Advisors’s Portfolio ARLZ Stock Details ARLZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-312,059
Closed -$468K – 3430
2018
Q1 		$468K Hold
312,059
– – ﹤0.01% 3117
2017
Q4 		$443K Hold
312,059
– – ﹤0.01% 3110
2017
Q3 		$714K Sell
312,059
-2,165
-0.7% -$2.9K ﹤0.01% 3053
2017
Q2 		$424K Hold
314,224
– – ﹤0.01% 3115
2017
Q1 		$672K Hold
314,224
– – ﹤0.01% 3050
2016
Q4 		$1.39M Buy
314,224
+7,014
+2% +$33.3K ﹤0.01% 2902
2016
Q3 		$1.49M Buy
307,210
+3,061
+1% +$14K ﹤0.01% 2848
2016
Q2 		$1M Sell
304,149
-154,710
-34% -$584K ﹤0.01% 2920
2016
Q1 		$1.63M Buy
+458,859
New +$2.37M ﹤0.01% 2823

Other funds holding ARLZ

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return
SM
Salzhauer Michael $212M AUM 20.86% 1-Year Est. Return
PCM
PAR Capital Management Boston, Massachusetts $3.44B AUM 28.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
SCP
Silverleafe Capital Partners Germantown, Tennessee $367M AUM 37.49% 1-Year Est. Return
FSA
Franklin Street Advisors Chapel Hill, North Carolina $1.79B AUM 28.1% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return